MedPath

HORUS PHARMA

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:5

Drug Approvals

4

CIMA_AEMPS:4

Drug Approvals

SINETRAV 40 MICROGRAMOS/ML COLIRIO EN SOLUCION

Approval Date
Jul 14, 2025
CIMA_AEMPS

KETISAL 0,25 MG/ML COLIRIO EN SOLUCION

Approval Date
Jul 14, 2025
CIMA_AEMPS

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (100.0%)

Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness

Not Applicable
Completed
Conditions
Dry Eye
First Posted Date
2024-09-23
Last Posted Date
2025-02-13
Lead Sponsor
Horus Pharma
Target Recruit Count
44
Registration Number
NCT06607237
Locations
🇵🇱

Eurofins Dermscan Poland, Gdańsk, Poland

🇵🇱

Tu sie Leczy, Gdańsk, Poland

Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness

Not Applicable
Completed
Conditions
Dry Eye
First Posted Date
2024-02-07
Last Posted Date
2025-02-13
Lead Sponsor
Horus Pharma
Target Recruit Count
85
Registration Number
NCT06245421
Locations
🇫🇷

Eurofins Dermscan, Aix-en-Provence, France

🇫🇷

Eurofins EVIC, Bordeaux, France

🇵🇱

Eurofins Dermscan Poland, Gdańsk, Poland

and more 2 locations

Evaluation of Neovis® Total Multi Versus Systane® Balance on Ocular Dryness Associated With Meibomian Gland Dysfunction

Not Applicable
Conditions
Dry Eye
Meibomian Gland Dysfunction
First Posted Date
2022-01-13
Last Posted Date
2022-01-13
Lead Sponsor
Horus Pharma
Target Recruit Count
120
Registration Number
NCT05191771

Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness

Not Applicable
Conditions
Dry Eye
First Posted Date
2018-08-24
Last Posted Date
2018-08-24
Lead Sponsor
Horus Pharma
Target Recruit Count
80
Registration Number
NCT03645850

Evaluation of the Efficacy and Safety of DM05 Versus Optive™ on the Treatment of Moderate to Severe Ocular Dryness

Not Applicable
Completed
Conditions
Dry Eye
First Posted Date
2018-05-07
Last Posted Date
2018-05-07
Lead Sponsor
Horus Pharma
Target Recruit Count
80
Registration Number
NCT03517748

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.